HZNP
$71.22
Horizon Therapeutics
$1.68
2.42%
HZNP
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  $1.01
Revenue:  $681.02 Mil
Monday
Feb 1
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when HZNP reports earnings?
Beat
Meet
Miss

Where is HZNP's stock price going from here?
Up
Flat
Down
Stock chart of HZNP
Analysts
Summary of analysts' recommendations for HZNP
Score
Grade
Pivots
Resistance
$75.11
$73.21
$72.22

$70.32

Support
$69.33
$67.43
$66.44
Tweet
Growth
Description
Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. Horizon Therapeutics PLC, formerly known as Horizon Pharma Public Limited Company, is headquartered in Dublin, Ireland.
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbZoetisMerck & Co.PfizerJohnson & JohnsonEli Lilly